LONG-FORM NOTICE OF SETTLEMENT APPROVAL HEARING NOTICE OF PROPOSED SETTLEMENT OF YASMIN AND YAZ LITIGATION Please read this Notice carefully – your legal rights may be affected. Notice of Settlement A Canada-wide settlement (“Settlement”) has been reached with Bayer Inc. and other Bayer defendants (collectively “Bayer”) in class actions in Ontario, Saskatchewan, and Quebec relating to the oral contraceptives Yasmin and YAZ. The class actions raise various allegations relating to blood clots (arterial thromboembolism, venous thromboembolism) and gallbladder disease and removal (cholecystectomy). Bayer denies the allegations made in the class actions, makes no admission as to the truth of these allegations, and denies any wrongdoing. The allegations made in the class actions have not been proven in court and should not be considered in any way to be medical advice. This Notice summarizes certain parts of the Settlement Agreement. All capitalized terms not otherwise defined in this Notice have the meanings given to them in the Settlement Agreement. If there is a conflict between the content of this Notice and the Settlement Agreement, the terms of the Settlement Agreement will prevail. This Notice advises you of the hearings that will be held to decide whether the Settlement should be approved. You may attend the Settlement Approval Hearings. You can review the Settlement Agreement and related documents on the Settlement Website: www.yasminyazclassactioncanada.ca. You can also contact Class Counsel using the information listed below. Who is included? If the Settlement is approved, it will apply to the following Settlement Class: (1) all persons resident in Canada who were prescribed and ingested Yasmin and/or YAZ between December 10, 2004 (in respect of Yasmin) or January 6, 2009 (in respect of YAZ) and November 30, 2011 (in the case of Ontario and Québec residents) or October 4, 2016 (in the case of Canadian residents outside Ontario and Québec) AND who were subsequently diagnosed with arterial thromboembolism, venous thromboembolism, and/or gallbladder disease; and (2) all persons resident in Canada who, by virtue of a personal relationship to any one or more of the persons described above, has a derivative claim for damages under Canadian family law legislation. What is the proposed Settlement? The Settlement provides for the creation of a CAD $9,050,000.00 Settlement Fund that will be used, among other things, to pay the costs of notice and administration of the Settlement, the claims of Provincial Health Insurers, Class Counsel legal fees, and benefits for Approved Claimants who are part of the Settlement Class. The final value of benefits for each Approved Claimant will not be determined until all Claims are submitted and considered by the Claims Administrator. To be eligible for benefits, individuals must be part of the Settlement Class and must submit a valid and timely Claim with supporting documents to the Claims Administrator. Not all Settlement Class Members or individuals who submit a Claim will receive benefits. 10% of the Settlement Fund (CAD $905,000.00) will be allocated to a Provincial Health Insurer Fund for the recovery of costs of insured health or medical services provided by the Provincial Health Insurers. If the Settlement is approved, Class Counsel will seek court approval for Class Counsel legal fees. Class Counsel Fees will be determined in accordance with the retainer agreement, which proposes a contingency fee of 30%, plus disbursements and applicable taxes, to be paid from the Settlement Fund. Approval of the Settlement is not Page 1 of 3 contingent on the outcome of any request regarding Class Counsel legal fees. The Courts may award something less than the amount requested by Class Counsel. Settlement Approval Hearings For the Settlement to become effective, it must be approved by the Ontario Superior Court of Justice, the Superior Court of Québec, and the Court of King’s Bench for Saskatchewan. These Courts must be satisfied that the Settlement is fair, reasonable, and in the best interest of the Settlement Class. The Settlement Approval Hearings have been set for: November 14, 2025: Ontario Superior Court of Justice; November 14, 2025: Superior Court of Québec; and November 21, 2025: Court of King’s Bench for Saskatchewan. In the event that the Settlement is not approved by the Courts in a form agreed to by the Plaintiffs and Defendants, the Settlement Agreement will terminate, and its terms will no longer be binding on the Settlement Class. In that case, all parties will be restored to their pre-Settlement Agreement positions. Objecting to the proposed Settlement and opportunity to appear If you wish to object to the proposed Settlement, you must submit a written objection no later than 5:00pm Eastern Time on October 14, 2025, containing the following information: • a heading that states: “Objection to Yasmin/YAZ Class Actions National Settlement”; • your full name, current mailing address, telephone number, and email address; • a brief explanation of the nature and reasons for your objection, along with any supporting documents; • a declaration that you believe you are a member of the Settlement Class and the reason for that belief; • whether you intend to appear at the Settlement Approval Hearing(s), in which Province you plan to attend, and, if you intend to appear represented by counsel, the name, address, telephone number, and email address of your counsel; and • your signature. Your written objection must be received by the Claims Administrator via pre-paid mail, courier, or email by no later than 5:00pm Eastern Time on October 14, 2025, at the applicable address listed below. The Claims Administrator will file copies of the objections received on time with the Courts. Epiq Class Action Services Canada Inc. Attn: YAZ/Yasmin Class Action P.O. Box 507 STN B Ottawa ON K1P 5P6 877-741-8728 www.yasminyazclassactioncanada.ca For general inquiries: Info@yasminyazclassactioncanada.ca For objections: Objection@yasminyazclassactioncanada.ca Page 2 of 3 If you plan to attend a Settlement Approval Hearing and you have submitted a written objection, you may request to make oral submissions to the Court. Notice of Settlement Approval If the proposed Settlement is approved by the Courts, a Notice of Settlement Approval will be published on www.yasminyazclassactioncanada.ca and otherwise made available as ordered by the Courts. Settlement Class Members will have a limited amount of time to submit a Claim for benefits. The applicable Claim Forms will be made available online at www.yasminyazclassactioncanada.ca or, alternatively, may be requested from the Claims Administrator via email, mail, or telephone using the information listed above. If you intend to submit a Claim, you must do so on or before the applicable deadline, which will be posted on the Settlement Website: www.yasminyazclassactioncanada.ca For more information If you have any questions regarding the proposed Settlement, information is available online by visiting the Settlement Website, www.yasminyazclassactioncanada.ca, or by contacting the toll-free, bilingual hotline: 877- 741-8728. You may also contact Class Counsel directly: ONTARIO OUTSIDE ONTARIO & QUÉBEC QUÉBEC McKenzie Lake Lawyers LLP Merchant Law Group Siskinds Desmeules 1800-140 Fullarton Street 2401 Saskatchewan Drive 43 rue de Buade #320 London, ON N6A 5P2 Regina, SK S4P 4H8 Québec City, QC G1R 4A2 Email: Email: yasminyaz@merchantlaw.com Email: christina.wolfe@mckenzielake.com recours@siskinds.com Telephone: 1(866)653-7777 Telephone: 519-672-5666 Telephone: 1 (877) 735-3842 306-540-2284 This Notice is a summary of the Settlement. You should consult the Settlement Agreement on the Settlement Website or contact Class Counsel or the hotline for specific details as to your rights and obligations under the Settlement. PLEASE DO NOT CALL THE DEFENDANTS OR THE COURT ABOUT THE PROCEEDING This Notice was approved by order of the Ontario Superior Court of Justice, the Superior Court of Québec, and the Court of King’s Bench for Saskatchewan. This is not a solicitation from a lawyer. The court offices will be unable to answer any questions about the matters in this Notice. Please do not contact them. Page 3 of 3